We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2013 by Rothman Institute Orthopaedics.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00951145
First Posted: August 4, 2009
Last Update Posted: April 9, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Stryker Orthopaedics
Information provided by:
Rothman Institute Orthopaedics
  Purpose
This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.

Condition
Osteoarthritis of the Hip

Study Type: Observational
Study Design: Observational Model: Case-Only
Official Title: Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem

Resource links provided by NLM:


Further study details as provided by Rothman Institute Orthopaedics:

Primary Outcome Measures:
  • The outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stem

Secondary Outcome Measures:
  • Proximally coated tapered stems can be used for patients with various bone types, bone morphology, and underlying diagnosis

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem
Criteria

Inclusion Criteria:

  1. All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem.
  2. Patients with hip fracture undergoing THA will also be included.
  3. Patients willing and able to comply with follow-up requirements and self-evaluations.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00951145


Locations
United States, Pennsylvania
Rothman Institute
Philadelphia, Pennsylvania, United States, 19107
Sponsors and Collaborators
Rothman Institute Orthopaedics
Stryker Orthopaedics
Investigators
Principal Investigator: Parvizi Javad, MD Rothman Institute
Principal Investigator: Hozack William, MD Rothman Institute
  More Information

Responsible Party: Javad Parvizi, MD, FRCS, Rothman Institute
ClinicalTrials.gov Identifier: NCT00951145     History of Changes
Other Study ID Numbers: RIFJPAR 09-01
First Submitted: July 31, 2009
First Posted: August 4, 2009
Last Update Posted: April 9, 2013
Last Verified: April 2013

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases